Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · CBD

Is CBD legal in Austria?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
Not a designated drug in Austria, and the reason is a finding rather than a silence. Pure cannabidiol is not named in the narcotics or psychotrope lists; its open ring structure is neither a tetrahydrocannabinol positional isomer nor one of the specified closed ring NPS cannabinoid cores, and the EU novel food regulation permits only authorised novel foods on the Union list to be marketed on the conditions that list sets. That is three separate negative findings and one positive obligation. Cannabis extracts, medicinal products and novel food uses each require their own conditions, so a CBD product is not automatically lawful because the molecule is unlisted.
Consequences if caught
Capital exposure: none. This row sits outside the drug ladder altogether, so neither the life ceiling in SMG §28a(5) nor any lesser SMG tier arises, and Austria has abolished capital punishment. CBD carries no SMG tier on the molecule itself, while the extract it came from may carry one, which is why the source material matters more than the cannabidiol content. Enforcement therefore runs through the authority that polices that instrument rather than through a drug prosecution, and the offence elements are the instrument's own. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.
If prescribed or medical
Austria publishes no per substance traveller route. SMG §5(1) is the single rule: a Suchtmittel may be handled only for medical, dental, veterinary or scientific purposes and only as the Act allows, with the travel, licensing and dispensing exemptions each governed by their own provisions. Because this is not a Suchtmittel at all, the authorized purpose rule in SMG §5(1) does not reach it, and neither the psychotrope medicine exception in SMG §30(3) nor the travel certificate fields closing the Psychotropenverordnung's Annexes 2 and 3 have anything to attach to. CBD is not a Suchtmittel, so no drug travel rule applies to it; a CBD medicinal product would be answered by the medicines act instead.
Documentation
Carry nothing under the drug instruments, because none of them designates this substance. The extract a CBD product came from can be controlled even where the cannabidiol itself is not. The product, food and consumer instruments were read on 18 September 2026, and the narcotics, psychotrope and NPS sweep that produced the negative findings was run on the same date.
Primary sources
  • Austria, the absence of a cannabidiol entry in the narcotics and psychotrope lists, the NPS cannabinoid core definitions, and the EU novel food authorisation requirement
  • the negative sweep covered the Suchtgiftverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011053, the Psychotropenverordnung at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=10011054 and the NPS regulation at https://www.ris.bka.gv.at/GeltendeFassung.wxe?Abfrage=Bundesnormen&Gesetzesnummer=20007642 with its structural annex at https://www.ris.bka.gv.at/Dokumente/Bundesnormen/NOR40261441/II_106_2024_Anlage_II.pdf
  • RIS is the official publisher
  • its open data notice at https://www.ris.bka.gv.at/UI/Ogd.aspx places the reused material under Creative Commons Attribution 4.0 International and requires attribution, and its imprint at https://www.ris.bka.gv.at/UI/Impressum.aspx identifies the signed authentic gazette instruments as the binding text and disclaims accuracy, currency and completeness for the consolidated versions
  • the novel food regulation was read at https://eur-lex.europa.eu/legal-content/DE/TXT/?uri=CELEX:32015R2283
  • at that placement the reading also covered this: three separate negatives were established in one pass, no narcotics or psychotrope entry, no fit to the enumerated tetrahydrocannabinol isomers, and no fit to the specified closed ring cannabinoid cores
  • read as at 18 September 2026.
  • the section 27, 35, 28 and 28a penalties stated above are carried forward from this site's published Austria entry, which cites the Suchtmittelgesetz and the Suchtgift-Grenzmengenverordnung. They were not re-derived from either instrument in this pass, and that entry's own framing, depenalised and not legalised and no legal minimum quantity, is carried with them

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Other substances confirmed in Austria